Login to view
Course Activities.
|
Title: |
Activity/Course #: |
Cost: |
Release/Start Date: |
Expiration Date: |
Topics: |
Target Audience: |
Medium/Method: |
Estimated Time To Complete CME Activity: |
Hardware/Software Requirements: |
Credits: |
|
This program was captured live at the NACE Emerging Challenges in Primary Care Series Update 2007 and features Dr. Phyliss Zee. Dr. Zee is Professor of Neurology and Neurobiology and Physiology at Northwestern University in Chicago, Illinois. Learning Objective(s): After completing this program participants should be able to::
- utilize diagnostic criteria for Restless Leg Syndrome and understand recent advances in the pathophysiology of the disease
- utilize current behavioral and pharmacologic treatment options to reduce symptoms and increase quality of life
This webcast was recorded live and is being used with the permission of the presenter. |
|
|
National Association for Continuing Education
|
| The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The National Association for Continuing Education designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
|
Phyllis Zee, MD, PhD made the following disclosures:
Grant support from the National Institutes of Heath, Boehringer Ingelheim, Sanofi-Aventis, Kyowa, Schwartz Biosciences, Takeda Pharmaceuticals of North America. She is a consultant for Boehringer Ingelheim, Sanofi-Aventis, Takeda Pharmaceuticals of North America, Neurocrine Biosciences, and Pfizer. She is on the speaker's burea for Takeda Pharmaceuticals of North America nad Sanofi-Aventis.
Gregg Sherman, MD, Course Director, has no relationships to disclose.
Harvey Parker, PhD, Activity Planning Committee, has no relationships to disclose.
Michelle Frisch, MPH, Activity Planning Committee, has no relationships to disclose.
Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose. |
|
No commercial support was provided for this enduring activity. The following companies provided commercial support for the live CME activity entitled Emerging Challenges in Primary Care: Update 2007 held in Birmingham, AL on March 31, 2007 during which this presentation was held:Amylin, AstraZeneca, Boehringer Ingelheim, Collagenex, Merck, NovoNordisk, sanofi-aventis, Takeda, Wyeth. |
|
